Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2021

Nov 15, 2021

30071_dirs_2021-11-15_76dd4964-acfa-4a4b-852a-a49e31a50078.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2021-11-11

Reporting Person: Ghoshal Kaushik (President, SaaS Business)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-11-11 ResMed Common Stock F 976 $259.47 Disposed 6424 Direct

Footnotes

F1: Disposition to issuer for tax withholding on vesting tranches of Restricted Stock Units granted for dates 11/14/2018, 11/21/2019 and 11/19/2021.

F2: Includes 29.706 shares of ResMed stock purchased on October 29, 2021, through the ResMed Employee Stock Purchase Plan.